2005
DOI: 10.1016/j.tripleo.2004.11.050
|View full text |Cite
|
Sign up to set email alerts
|

Oral plasmablastic lymphoma in an HIV-negative patient: A case report and review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
78
0
13

Year Published

2007
2007
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 70 publications
(92 citation statements)
references
References 23 publications
1
78
0
13
Order By: Relevance
“…Originally PBL was described in the oral cavity region although, many reports of patients without HIV and outside the head and neck area have been recently presented in the literature [10,13,[16][17][18][19].…”
Section: Discussionmentioning
confidence: 99%
“…Originally PBL was described in the oral cavity region although, many reports of patients without HIV and outside the head and neck area have been recently presented in the literature [10,13,[16][17][18][19].…”
Section: Discussionmentioning
confidence: 99%
“…Subsequent publications with larger case studies have shown that PBL is not restricted to the oral cavity, but may also present at other mucosal sites in the head and neck, bone, soft tissue, gastrointestinal tract, and spermatic cord [3,8]. Although the majority of these cases occur in association with HIV-infection, a small subset is associated with immunosuppression after solid organ transplantation or steroid therapy and very rare cases occur in immunocompetent patients [1,6,9]. Morphology of these subsequently reported cases vary from a monotonous proliferation of lymphoid cells with immunoblastic features and minimal plasmacytic differentiation to a variable mixture of large immunoblasts and plasmablasts with cells showing differentiation to mature plasma cells [1,9].…”
Section: Discussionmentioning
confidence: 99%
“…Immunophenotyping consistently shows strong CD138 and VS38c expression, variable expression of CD79a, EBER reactivity in the majority of cases, and absent or very weak expression of CD20 [1][2][3][4][5][6]. The clinical behavior has been reported as highly aggressive with generally poor response to therapy and short survival ranging between 1 and 28 months after diagnosis [1,4,9].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…128,129,130 The median age at presentation is approximately 30-50 years. However, a broad age range from 7 to 75 years exists.…”
Section: Epidemiologymentioning
confidence: 99%